Associate Principal Investigators and the HEAL-COVID trial: good for trainees, good for trials.
Joseph NewmanPhilip Wildnull nullCharlotte SummersMark ToshnerPublished in: Trials (2024)
This study adds to the growing literature that the NIHR's API Scheme is effective in meeting its objectives in providing research training to clinicians, thus building a workforce of future clinical researchers. Moreover, data from the HEAL-COVID trial shows that sites with an API are associated with higher recruitment. Overall, registering a trial with the API Scheme not only trains future clinical researchers, but it is also likely to increase the number of patients recruited (amongst other benefits), increasing the efficiency of trials and improving access for patients.
Keyphrases
- end stage renal disease
- coronavirus disease
- clinical trial
- newly diagnosed
- study protocol
- sars cov
- chronic kidney disease
- ejection fraction
- systematic review
- phase iii
- prognostic factors
- public health
- phase ii
- primary care
- randomized controlled trial
- machine learning
- current status
- patient reported outcomes
- deep learning
- mass spectrometry
- open label
- high speed
- visible light